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OBJECTIVE — Our goal was to ascertain the prevalence of pruritus in diabetic and nondia-
betic subjects and the relevance of symptoms, signs, and nerve functions of diabetic polyneu-
ropathy (DPN) of pruritus.
RESEARCH DESIGN AND METHODS — A large-scale survey of 2,656 diabetic out-
patients and 499 nondiabetic subjects was performed. In diabetic subjects, the relationship
between pruritus and age, sex, diabetic duration, A1C, Achilles tendon reﬂex (ATR), and ab-
normal sensation in legs was evaluated. In 105 diabetic subjects, nerve conduction studies,
quantitativevibratorythreshold(QVT),heartratevariability,andafallofsystolicbloodpressure
at a head-up tilt test (BP) were performed, and the relationships between pruritus and nerve
functions were evaluated.
RESULTS — Although the prevalence of truncal pruritus of unknown origin (TPUO) in
diabeticsubjectswassigniﬁcantlyhigherthanthatinage-matchednondiabeticsubjects(11.3vs.
2.9%, P  0.0001), the prevalence of other pruritus was not different between the two groups.
Multiple logistic regression analysis revealed that abnormal sensation and ATR areﬂexia were
independent risk factors for TPUO in age, sex, duration of diabetes, and A1C. BP in diabetic
subjects with TPUO was signiﬁcantly impaired compared with that in those without TPUO.
Larger BP was identiﬁed as a signiﬁcant risk factor of TPUO independent of other nerve
dysfunctions by multiple logistic regression analysis.
CONCLUSIONS — TPUO is signiﬁcantly more frequent in diabetic than in nondiabetic
individuals. TPUO is signiﬁcantly associated with symptoms and signs of DPN, including im-
paired blood pressure response in a head-up tilt test. TPUO, therefore, might be a newly
recognized symptom of DPN.
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W
e have an unproven idea that di-
abetic patients complain of pru-
ritus more frequently than the
general population does. A textbook of
diabetology also describes this uncer-
tainty as follows, “The frequency of gen-
eralized pruritus in diabetes is unknown;
however, many believe that it is increased
in diabetes” (1). As an itching sensation is
thoughttobetransmittedbysmallunmy-
elinatedsensoryc-ﬁbers(2),pruritusmay
reﬂectsomeabnormalityoftheperipheral
nerve. In this study, we sought to clarify
the prevalence of pruritus in diabetic and
nondiabetic subjects and the relevance of
pruritus to the symptoms and signs of di-
abetic polyneuropathy (DPN) using a
large-scalequestionnairesurvey.Further-
more, the relationships between pruritus
and quantitatively assessed nerve func-
tions were also examined.
RESEARCH DESIGN AND
METHODS— The study comprised
two investigations. The ﬁrst investigation
consisted of a questionnaire to assess the
prevalenceofpruritusanditsrelevanceto
neuropathic symptoms and signs. The
second investigation was performed us-
ing quantitative neurological function
teststodeterminewhatkindofnervedys-
function is related to pruritus.
Prevalence of pruritus and its
relevance to symptoms and signs of
DPN
A large-scale survey of diabetic subjects
was performed with the cooperation of
the physicians of the Wakayama medical
association. Between November 2006
and August 2007, questionnaires were
sent to 48 medical practitioners and hos-
pital physicians in Wakayama Prefecture,
Japan. The questionnaires consisted of
patient- and physician-completed por-
tions, and both were returned to our de-
partment for analysis. A survey of
nondiabetic subjects was performed with
thecooperationofthehealthexamination
divisionofWakayamaRosaiHospital.Be-
tween September 2006 and August 2007,
the same questionnaires were used for
nondiabetic subjects who had received
annual medical examinations at their
workplace. Participation was voluntary,
and data that could identify individuals
was not collected.
Items in questionnaire
Age (expressed as decade), sex, height,
and body weight were obtained from all
participants. Duration of diabetes, most
recent A1C measurement, and Achilles
tendonreﬂex(ATR)wereprovidedbythe
physicians treating the diabetic partici-
pants. Subjective sensory symptoms were
examined in diabetic and nondiabetic
participants using four criteria: “numb-
ness in toes and soles,” “dysesthesia in
toesandsoles,”“paininfeet,”and“painful
legcramp.”Inthisstudy,“numbness”was
deﬁnedasanabnormalsensationwiththe
absence of stimulation, and “dysesthesia”
was deﬁned as an abnormal sensation
producedbyordinarystimuli.Finalques-
tions to diabetic and nondiabetic subjects
concerned “pruritus” and its distribution
in the body and the suspected cause of
itching.Prevalenceofpruritusandabnor-
mal sensations were compared between
diabetic and nondiabetic participants.
The relations between pruritus and neu-
rologicalsymptoms,signs,andotherclin-
ical factors described above were also
evaluated in diabetic participants.
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pruritus
A total of 105 diabetic subjects (58 men
and 47 women) aged 70 years who re-
ceived medical interviews and quantita-
tive nerve function tests were enrolled in
this study. Forty-four patients were out-
patients and 61 were inpatients of the
Wakayama Medical University Hospital.
Numbers of patients receiving insulin
therapy with or without additional oral
agents, oral hypoglycemic agents, and
only diet/exercise therapy were 73, 29,
and3,respectively.TheirmeanSDage,
durationofdiabetes,BMI,andrecentA1C
were 55.7  9.6 years, 11.6  8.8 years,
24.8  4.3 kg/m
2, and 8.6  2.1%, re-
spectively. Prevalence of proteinuria
(intermittent and persistent protein-
uria) and retinopathy (simple preprolif-
erative and proliferative retinopathy)
was 29.1 and 45.9%, respectively. Sub-
jects with systolic blood pressure 130
mmHg and/or diastolic blood pressure
85mmHgorthosereceivingantihyper-
tensive treatment were deﬁned as hyper-
tensive. Subjects with total cholesterol
5.69mmol/l(220mg/dl)and/ortriglyc-
erides 1.70 mmol/l (150 mg/dl) or
those receiving antihyperlipidemia medi-
cation were deﬁned as hyperlipidemic.
The prevalence of hypertension and hy-
perlipidemia was 46.7 and 48.5%,
respectively.
Nerve function tests
Four objective and quantitative tests
(nerve conduction study, quantitative vi-
bratory perception test, head-up tilt test,
and heart rate variability test) were per-
formed to evaluate the relationships be-
tween pruritus and various somatic and
autonomic nerve functions. All examina-
tions were conducted in a temperature-
controlled room at 25°C. Methods for
each examination are described only
brieﬂy in the following because they were
described in our previous report (3).
Nerve conduction study. Motor nerve
conduction velocity (MCV) between the
wrist and elbow, compound muscle ac-
tion potential (CMAP) of the ulnar nerve,
sensory nerve conduction velocity (SCV)
betweenthewristandelbow,andsensory
nerve action potential (SNAP) of the me-
dian nerve were measured using standard
methods. Examinations were performed
bilaterally, and an average value was used
for analysis.
Quantitative vibratory perception
threshold test. The quantitative vibra-
tory perception threshold (QVT) at 125
Hz was semiquantitatively assessed at the
tipsofbigtoesusingavibratorysensation
meter (AU02A; RION, Tokyo, Japan).
Autonomic nerve function tests
(head-up tilt test and heart rate vari-
ability test). Sympathetic vasomotor
function was evaluated by a head-up tilt
test. Orthostasis-induced decreases in
brachial systolic blood pressure after pas-
sive standing in a 70° head-up position
(BP) were examined. Parasympathetic
cardiovagalfunctionwasevaluatedbythe
heart rate variability test. Coefﬁcients of
variationofRRintervalsontheelectrocar-
diogram during deep breathing (CV-DB)
were determined.
Comparisons between pruritus and
neurological functions
Actual data from neurological examina-
tions and the prevalence of impaired val-
ueswerecomparedbetweenpatientswith
and without pruritus. Because nerve con-
duction data (MCV, SCV, CMAP, and
SNAP) and vibratory thresholds (QVT)
weredistributednormally,valuesexceed-
ing the range of means  2S Do ft h e
healthy subjects in our institute (4) were
judged as impaired. CV-DB results that
were converted into logarithms were dis-
tributed normally, and data that were
morethanthemeans2SDoflogarithms
ofhealthysubjects(5)wasconsideredim-
paired. Because BP values in the
head-up tilt test were not distributed nor-
mally, decisions regarding impairment
were judged according to the criteria of
the American Autonomic Society (6): a
decrease in upright systolic blood pres-
sure of at least 20 mmHg.
Statistical analysis
DataareexpressedasmeansSD.Statis-
tical analyses were performed by 
2 test,
unpaired t test, and multiple logistic re-
gression analysis using statistical software
(Statview-J5.0TM; Hulinks, Tokyo, Japan).
P  0.05 was considered signiﬁcant.
RESULTS
Prevalence of pruritus and its
relevance to symptoms and signs of
DPN
Questionnaires were collected from a to-
tal of 3,042 diabetic patients, with an av-
erageof64perclinicorhospital.Thedata
for 386 diabetic subjects who did not re-
ply to the questions concerning pruritus
wereexcludedfromanalysis,andthedata
Table1—Comparisonoftheprevalenceofneurologicalsymptoms,pruritus,andsubclassiﬁed
pruritus between age-matched diabetic and nondiabetic subjects and the relevance of TPUO
with the signs and symptoms of DPN
Inﬂuence of diabetes Inﬂuence of TPUO
Nondiabetic Diabetic TPUO() TPUO()
n 391 391 2,172 316
Sex (male/female) 239/144 229/162 1,186/943 160/151
Age (years) NE NC 60.2  12.0 63.1  12.3*
Duration (years) NE 8.4  7.1 10.9  8.5 13.5  9.5*
BMI (kg/m
2) 22.5  3.3 25.1  4.8† 24.0  4.3 24.0  5.0
A1C (%) NE 7.3  1.5 7.0  1.4 7.1  1.2
Numbness in toes and soles (%) 8.0 27.5† 27.6 41.3*
Dysesthesia in toes and soles (%) 4.4 16.6† 17.9 28.6*
Pain in feet (%) 4.4 9.6‡ 8.7 16.6*
Painful leg cramp (%) 36.1 31.8 34.0 47.4*
Bilateral areﬂexia in ATR (%) NE 16.7 18.1 34.3*
Pruritus (%) 14.6 26.3† 14.9 100*
TPUO (%) 2.9 11.3† 0 100*
Head and neck pruritus of
unknown origin (%) 0.8 0 NC NC
Leg pruritus of unknown
origin (%) 1.1 1.6 NC NC
Pruritus due to dermatitis (%) 4.1 4.1 NC NC
Pruritus due to athlete’s foot
(%) 1.5 3.8‡ NC NC
Data are means  SD or %. Statistical analyses were made by unpaired t test and 
2 test. *P  0.001 vs.
TPUO().†P0.001vs.nondiabeticsubjects.‡P0.05vs.nondiabeticsubjects.NC,notcalculated;NE,
not examined.
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(1,440 men, 1,161 women, and 55 not
speciﬁed) were included. Their ages were
distributed from 20 to 80 years. Half of
the subjects included were aged 60 or
70 years. Average  SD duration of dia-
betes was 11.4  8.8 years, and A1C was
7.05  1.34%. Questionnaires were col-
lected from 499 nondiabetic subjects
(307 men, 170 women, and 22 not spec-
iﬁed).Althoughtheiragedistributionwas
also from 20 to 80 years, half of those
included were aged 40 and 50 years and
were signiﬁcantly younger than the dia-
betic subjects.
Prevalence of pruritus and
symptoms and signs of DPN
Becauseofthesigniﬁcantdifferenceinthe
age distribution between diabetic and
nondiabetic subjects, the prevalence of
pruritus, abnormal sensations, and pain-
ful leg cramp was calculated in age-
matched diabetic and nondiabetic
samples and compared between the two
groups. The same numbers of diabetic
and nondiabetic subjects for the analysis
were randomly selected for each decade
of age using a stratiﬁed sampling method.
Therefore, the data from 391 participants
from each group (aged 20–29 years, n 
9;30–39years,n62;40–49years,n
121;50–59years,n122;60–69years,
n  57; 70–79 years, n  16; and 80
years,n4)wereevaluated.Prurituswas
subclassiﬁedbyitchingsiteandcauseinto
ﬁve categories: truncal pruritus of un-
known origin (TPUO), head and neck
pruritus of unknown origin, leg pruritus
of unknown origin, pruritus caused by
dermatitis, and pruritus due to athlete’s
foot. Frequency was also examined.
The prevalence of numbness in toes
and soles, dysesthesia in toes and soles,
pain in feet, and pruritus in diabetic sub-
jects was signiﬁcantly higher than that in
nondiabetic subjects. The prevalence of
painful leg cramps was not different be-
tween the two groups. The prevalence of
total pruritus in diabetic subjects was sig-
niﬁcantly higher than that in nondiabetic
subjects (26.3 vs. 14.6%, P  0.001). In
subclassiﬁed pruritus, TPUO occurred
more frequently in diabetic than in non-
diabetic subjects (11.3 vs. 2.9%, P 
0.001), and the prevalence of pruritus
due to athlete’s foot was higher than that
in nondiabetic subjects (P  0.047).
However, the prevalence of pruritus in
other sites and that due to dermatitis was
not different between the two groups.
Therefore, the characteristic pruritus in
diabetic subjects seemed to be TPUO.
TPUO was seen in 12.7% (316 of 2,488)
of the total diabetes group. In the patients
with DPN judged by bilateral ATR
areﬂexia, the prevalence of TPUO was
20.5% (84 of 410). In the asymptomatic
patients with DPN who complained of no
abnormal sensation, TPUO was observed
in 15.2% (31 of 204). There was no sig-
niﬁcantsexdifferenceintheprevalenceof
TPOU in diabetic and nondiabetic
subjects.
Relevance of pruritus to signs and
symptoms of DPN
The age of patients with TPUO and dura-
tionofDPNweresigniﬁcantlyhigherthan
those of patients without TPUO. The
prevalence of all symptoms of DPN
(numbness in toes and soles, dysesthesia
in toes and soles, pain in feet, and painful
leg cramps) and bilateral areﬂexia of ATR
Figure 1—Multiple logistic regression analysis with TPUO as an independent variable revealed that dysesthesia, ATR areﬂexia, and duration were
signiﬁcantriskfactorsforTPUOwithoddsratiosof1.649,1.811,and1.264,respectively.Horizontalcolumnsshowthe95%CIsofeachindependent
factor.
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cantly higher than those in the patients
without TPUO (Table 1). Thus, multiple
logisticregressionanalysiswasperformed
to conﬁrm the risk factors for TPUO.
Seven clinical factors were correlated into
scores(age:60years,0,60–69years,1,
and70years,2;sex:female,0andmale,
1; duration of diabetes: 5 years, 0, 5–9
years, 1, and 10 years, 2; BMI: 22.0
kg/m
2, 0, 22.0–24.9 kg/m
2,1 ,a n d25.0
kg/m
2,2;A1C:6.5%,0,6.5–7.9%,1,and
8.0%,2;dysesthesia:no,0andyes,1;and
absence of both ATR: no, 0 and yes,1)
andadoptedasindependentvaluables.Asa
result, numbness in toes and soles, ATR
areﬂexia, and longer duration of diabetes
were identiﬁed as the independent risk fac-
tors of TPUO (Fig. 1).
Nerve dysfunctions associated with
pruritus
The prevalence of total pruritus and
TPUOin105diabeticpatientswas32and
19%, respectively. There was no signiﬁ-
cant difference in all clinical background
data between TPUO() and TPUO()
groups (Table 2). In the comparison of
actual neurological data, only BP in the
TPUO() group was signiﬁcantly higher
than that in the TPUO() group. In the
comparison of prevalence of impaired
nerve functions, impaired BP and
CV-DB occurred in a signiﬁcantly higher
frequency in the TPUO() group than in
the TPOU() group (Table 2). Multiple
logistic regression analysis was also per-
formedtoexamineneurologicalfunction,
which is closely related to TPUO. Seven
clinical and neurological factors were
converted into scores (age: 50 years, 0,
50–59 years, 1, and 60 years, 2; sex:
female, 0 and male, 1; duration of diabe-
tes, 5 years, 0; 5–9 years, 1, and 10
years, 2; impaired SCV: no, 0 and yes, 1;
impaired CV-DB: no, 0 and yes, 1; im-
paired BP: no, 0 and yes, 1; and im-
paired QVT: no, 0 and yes, 1), and they
were adopted as independent variables,
respectively. As a result, impaired BP
wasidentiﬁedasasigniﬁcantriskfactorof
TPUO (Fig. 2).
CONCLUSIONS — The ﬁrst investi-
gation (a large-scale survey) revealed the
following three ﬁndings: 1) the preva-
lence of pruritus, especially TPUO, in di-
abetic patients was signiﬁcantly higher
than that in age-matched nondiabetic
subjects; 2) 	12% of diabetic outpatients
of general physicians complained of
TPUO,andthisprevalencewasfourtimes
that of nondiabetic subjects; and 3) bilat-
eral sensory symptoms in the feet and
ATR areﬂexia occurred in a signiﬁcantly
higherfrequencyindiabeticsubjectswith
TPUO than in diabetic subjects without
TPUO, and numbness in toes and soles
and ATR areﬂexia were identiﬁed as sig-
niﬁcant risk factors of TPUO by multivar-
iate analysis. From these ﬁndings, TPUO
was suspected of being a complication of
diabetes,andDPNwassuspectedofbeing
a possible origin of TPUO.
The second investigation, using sev-
eral quantitative nerve function tests, re-
vealed the following two ﬁndings: 1)
impaired blood pressure response to a
head-up tilt test and impaired heart rate
variability during deep breathing oc-
curred in a signiﬁcantly higher frequency
in TPUO() diabetic subjects than in
TPOU() diabetic subjects; and 2) only
impaired blood pressure responses to
head-up tilt were identiﬁed as signiﬁcant
risk factors of TPUO by multivariate anal-
ysis. These ﬁndings suggested that auto-
nomic nerve dysfunction, especially
sympathetic nerve dysfunction, might
be the most plausible candidate for the
origin of TPUO.
Many clinicians may have an impres-
sion that pruritus is more frequent in di-
abetic patients than in nondiabetic
individuals. Although pruritus in the feet
due to tinea pedis and pudendal pruritus
due to candidiasis have been reported to
be highly prevalent in diabetic patients
(7,8), there is little epidemiological evi-
dence of pruritus with diabetes. In this
study,weclearlydemonstratedthehigher
prevalence of TPUO in diabetic than in
nondiabetic subjects, and TPUO was ob-
served in 	12% of general diabetic out-
patients in a frequency similar to that of
the symptom of “pain in feet.” On the
other hand, the prevalence of pruritus in
the head and neck or legs and pruritus
caused by dermatitis were not different
between diabetic and nondiabetic
subjects.
The etiology of TPUO has not been
elucidated. Our survey showed that
TPUO was signiﬁcantly associated with
sensory disturbance in the legs and
areﬂexia of ATR. These ﬁndings were
thought to be characteristic for DPN (9).
Moreover, detailed neurological evalua-
tion indicated that an impaired blood
pressure response to a head-up tilt test
Table 2—Clinical characteristics and neurological data of diabetic patients divided into two
groups based on TPUO
TPUO() TPUO() P
n (%) 20 (19.0) 85 (81.0)
Age (year) 58.0  11.3 (20) 55.2  9.1 (85) 0.238
Sex (male/female) 11/94 7/38 0.981
BMI (kg/m
2) 24.2  4.5 (19) 24.9  4.3 (83) 0.487
A1C (%) 8.5  1.8 (18) 8.7  2.1 (83) 0.774
Duration of diabetes (years) 12.8  8.2 (20) 11.4  8.9 (85) 0.534
Proteinuria (more than intermittent
proteinuria) (%) 8/20 (40.0) 22/83 (26.5) 0.233
Retinopathy (more than SDR) (%) 12/20 (60.0) 32/76 (42.1) 0.153
Dyslipidemia (%) 10/20 (50.0) 41/85 (48.2) 0.887
Hypertension (%) 11/20 (55.0) 38/85 (44.7) 0.406
MCV (m/s) 49.9  5.2 (20) 50.9  5.1 (84) 0.396
Prevalence of impaired MCV (%) 8/20 (40.0) 28/84 (33.3) 0.573
CMAP (mV) 5.92  1.2 (19) 6.35  2.1 (84) 0.384
Prevalence of impaired CMAP (%) 5/20 (25.0) 16/83 (19.3) 0.569
SCV (m/s) 55.4  5.5 (19) 56.6  4.9 (78) 0.355
Prevalence of impaired SCV (%) 11/19 (55.0) 32/81 (39.5) 0.210
SNAP (
V) 24.8  16.4 (20) 25.3  18.7 (79) 0.909
Prevalence of impaired SNAP (%) 4/20 (20.0) 16/80 (20.0) 0.999
QVT (dB) 21.2  9.5 (20) 19.4  9.4 (85) 0.376
Prevalence of impaired QVT (%) 9/20 (45.0) 25/85 (29.4) 0.180
BP (mmHg) 19.2  15.8 (20) 10.4  15.2 (84) 0.014
Prevalence of impaired BP (%) 13/20 (65.0) 17/84 (20.2) 0.001
CV-DB (%) 4.29  3.56 (19) 4.91  3.99 (83) 0.538
Prevalence of impaired CV-DB (%) 10/20 (50.0) 23/85 (27.1) 0.047
Data are means  SD (n) unless indicated otherwise. n  105. Statistical analyses were made by unpaired t
test and 
2 test.
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This impairment reﬂected the deteriora-
tion of sympathetic nerve function (10).
We therefore think that TPUO is a symp-
tom of DPN, especially in sympathetic
nerve dysfunction. Two possible mecha-
nisms are proposed as an etiological the-
ory of TPUO. First, because sympathetic
nerve function includes the sudomotor
function (11), sympathetic dysfunction
caused hypohydrosis and resulted in dry
skin.Itiswellknownthatpruritusoccurs
frequently with dry skin. In dry skin the
barrier function of the skin is decreased,
and the threshold for itching is lowered;
therefore, TPOU is elicited. In fact, in-
creased numbers of mast cells and hista-
mine content have been reported in
experimentaldryskininmice(12).Asec-
ond possibility is that the damage to sen-
sory c-ﬁbers by DPN causes pruritus
directly. Superﬁcial skin pain is consid-
ered to be caused by abnormal ﬁring of
the pain nerve ﬁber in patients with DPN
(13). Similarly, abnormal ﬁring of the
nerveﬁberinpruritusmayinduceTPUO.
In fact, hyperplasia of the c-ﬁbers in the
epidermishasbeenreportedindermatitis
with strong pruritus (14). The unmyeli-
nated c-ﬁber that transmits pruritus is a
ﬁber similar to the sympathetic nerve
ending in the skin. Thus, a signiﬁcant as-
sociation between TPUO and orthostatic
intolerance seems to be reasonable. Both
of the two etiological factors, the dry skin
due to sudomotor hypofunction and di-
rect nerve ﬁber damage by DPN, may be
involved in TPUO. To determine the eti-
ology of TPOU accurately, a skin biopsy
and nerve ﬁber staining with antiprotein
gene product 9.5 antibody in patients
with TPUO will be necessary (15). Al-
thoughdiscussionoftreatmentofdiabetic
truncal pruritus is beyond the scope of
this study, two kinds of drugs might be
useful.Oneisanantihistaminicagentthat
may be effective for mild pruritus due to
dry skin and the other is a neurotropic
agent such as gabapentin that may be ef-
fective for severe TPUO such as uremic
pruritus (16).
From the viewpoint of clinical prac-
tice,TPUOseemstobeusefulfornotmis-
diagnosingDPN.Someinvestigatorshave
reportedthat	50%ofpatientswithDPN
did not complain of sensory disturbance
in their legs, which is a symptom typical
of DPN (17). It is therefore necessary to
do a neurological examination such as vi-
bratoryperceptionthresholdandATRfor
the diagnosis of DPN. However, it is not
feasible to examine ATR and vibratory
perception threshold in all diabetic out-
patients because of the remarkable
increase in the diabetic population. Con-
sequently, it is important to be familiar
withthesymptomsofDPNotherthanthe
sensory disturbance of the legs. By recog-
nizing TPUO as a subjective symptom of
DPN, it may be possible to reduce the
misdiagnosis of DPN. Indeed, 15% of
asymptomatic patients with DPN, who
showed bilateral ATR areﬂexia and no ab-
normal sensations, complained of TPUO
in our questionnaire survey.
Insummary,theprevalenceofTPUOin
diabetic patients is signiﬁcantly higher than
that in nondiabetic individuals, and TPUO
is signiﬁcantly associated with symptoms
and signs of DPN, one of which is ortho-
static hypotension. TPUO, therefore, may
be a newly recognized symptom of DPN.
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Figure2—MultiplelogisticregressionanalysisclariﬁedthattheonlysigniﬁcantriskfactorforTPUOwastheimpairmentofbloodpressureresponse
to a head-up tilt test, and the odds ratio was 8.218. Horizontal columns show the 95% CIs.
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